Validation and Implementation of Polygenic-Risk Prediction Models for Anthracyclines and Cisplatin in Pediatric Oncology
Validation and Implementation of Polygenic-Risk Prediction Models for Anthracyclines and Cisplatin in Pediatric Oncology
儿科肿瘤学中蒽环类药物和顺铂多基因风险预测模型的验证和实施
批准号：
429174
负责人：
Siemens Angela
金额：
$1.27万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-12-01 至 2020-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
"Advancement in cancer therapy over the past several decades has allowed most children battling cancer today to survive beyond 5 years. With increasing survival, the lasting effects of cancer therapy are becoming a more prevalent issue. Anthracyclines and
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
